Assignee
AGEX THERAPEUTICS INC
US·4 granted patents·17 pending applications·3 citations·filing 2014–2025
Top patents by PatentIndex Score
21 records- 0184US10961531B2Compositions and methods for induced tissue regeneration in mammalian speciesAGEX THERAPEUTICS INC·Filed 2014·Granted Mar 30, 2021·2 cites·26 claims
- 0276US10502738B2HLA G-modified cells and methodsAGEX THERAPEUTICS INC·Filed 2017·Granted Dec 10, 2019·1 cites·13 claims
- 0376US2025346862A1Methods for the re-derivation of diverse pluripotent stem cell-derived brown fat cellsAGEX THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0474US11977073B2HLA G-modified cells and methodsAGEX THERAPEUTICS INC·Filed 2019·Granted May 7, 2024·0 cites·43 claims
- 0572US2022160833A1Methods for detecting and modulating the embryonic-fetal transition in mammalian speciesAGEX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0672US2022088137A1Methods for detecting and modulating the embryonic-fetal transition in mammalian speciesAGEX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0771US2022088138A1Methods for detecting and modulating the embryonic-fetal transition in mammalian speciesAGEX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0870US2023093399A1Methods for generating pluripotent stem cell-derived brown fat cellsAGEX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0965US2020309776A1Hla g-modified cells and methodsAGEX THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1065US2024350553A1Methods for modulating the regenerative phenotype in mammalian cellsAGEX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1162US12404493B2Methods for the re-derivation of diverse pluripotent stem cell-derived brown fat cellsAGEX THERAPEUTICS INC·Filed 2018·Granted Sep 2, 2025·0 cites·12 claims
- 1262US2022316013A1Differentially-methylated regions of the genome useful as markers of embryo-adult transitionsAGEX THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1362US2024158788A1Methods and compositions used to modify chromatin architecture to regulate phenotype in aging and cancerAGEX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1460US2025216377A1Compositions and methods for detecting cardiotoxicityAGEX THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1559US2024066070A1Methods for the ex vivo induction of tissue regeneration in microbiopsiesAGEX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1658US2022401494A1Pericyte cell exosomesAGEX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1756US2020225213A1Compositions and methods for detecting cardiotoxicityAGEX THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1852US2021180013A1Improved methods for inducing tissue regeneration and senolysis in mammalian cellsAGEX THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1952US2021338822A1Therapeutic exosomes and method of producing themAGEX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2047US2020306296A1Induced tissue regeneration using extracellular vesiclesAGEX THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2147US2019151372A1Pericyte cell exosomesAGEX THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →